Yameng Sun

机构：Renji Hospital · ORCID：0000-0003-2981-9936

发表论文 136 篇 · 总被引 2854 次 · h-index 28

代表论文

• AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation (2024 · Signal Transduction and Targeted Therapy · 被引 21)
• Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation (2025 · Theranostics · 被引 11)
• Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study (2025 · Hepatology · 被引 10)
• Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction‐associated steatohepatitis: A nested case–control study of UK Biobank proteomic data (2025 · Diabetes Obesity and Metabolism · 被引 6)
• Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment (2025 · Nature Communications · 被引 5)
• Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis (2025 · Alimentary Pharmacology & Therapeutics · 被引 4)